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Objectives. The purpose of this study was to use intravascular 
ultrasound to determine the morphologic appearance of the 
coronary arteries, relating the absence, presence and extent of 
atherosclerosis to the response of the coronary arteries to acetyl- 
choline infusion. 
Background. Endothelial function plays a major role in the 
pathophysiology of myocardial ischemia and angina pectoris. The 
response of the coronary arteries to selective infusion of acetyl- 
choline has been used to examine endothelial function, with 
vasoconstriction occurring in the absence of intact endothelial 
function. Vasoconstriction to acetylcholine infusion in humans 
without overt coronary artery, disease has been attributed to early 
atherosclerosis not detected by coronary angiography. 
Methods. Twenty-nine patients without overt coronary artery 
disease underwent selective coronary angiography and selective 
intracoronary infusion of increasing concentrations of acetylcho- 
line (10 -6, 10 -5 and 10 -4  moi/liter), followed by intravascular 
ultrasound imaging. 
Results'. The response of the coronary arteries to acetylcholine 
infusion was not dependent on the absence or presence of athero- 
sclerotic plaque, as detected by intravascular ultrasound. The 
percent change in epicardial coronary artery diameter during 
acetylcholine infusion versus baseline was -14 -+ 28% (mean + 
SD) in the seven patients with no visible atherosclerosis on 
intravascular ultrasound versus -9  +- 20% in the 22 patients with 
visible atherosclerosis on intravascular ultrasound (p = NS, 
confidence interval -14% to 25%). There was a greater vasocon- 
strictive response to acetylcholine infusion in patients with risk 
factors for coronary artery disease than in those without risk 
factors (p = 0.003). 
Conclusions. The vasoreactive response to acetylcholine is not 
necessarily dependent on ultrasound detection of the presence or 
absence of atheroselerosis. 
(J Am CoU Cardiol 1995;26:41-9) 
Changes in vasomotor tone of the epicardial coronary arteries 
play a major role in the pathophysiology of myocardial isch- 
emia and angina pectoris (I,2). The role of the vascular 
endothelium in the control of arterial tone has been recog- 
nized (3-5). Vasomotor esponses to various stimuli are 
thought to be mediated by the release of vasodilators, uch as 
endothelial-relaxing factor, from intact endothelial cells. The 
lack of a vasodilator response implies endothelial dysfunction. 
Acetylcholine has been used to examine this response by 
the vascular endothelium. Normal arterial segments in vitro 
will dilate when exposed to acetylcholine in a specific dose 
range but will constrict in response to acetylcholine after 
mechanical removal of the endothelium (3). When acetylcho- 
line is infused into coronary arteries of patients with angio- 
graphic evidence of diffuse coronary' disease, vasoconstriction 
occurs, which is presumed to be a direct effect of acetylcholine 
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on the medial smooth muscle in the absence of release of 
vasodilators, uch as endothelial-relaxing factor (6-8). When 
acetylcholine is infused into angiographically normal coronary 
arteries in young patients with no risk factors for coronary 
artery disease, vasodilatation occurs, thought o be due to 
release of endothelial-relaxing factor by normal endothelium. 
Angiographically smooth vessels constrict in response to infu- 
sion of aceWlcholine in older patients (9), in patients with 
visible disease in other vessels (10) and in patients with risk 
factors for coronary artery disease (11-15). It has been postu- 
lated (6,7,9,11,16) that hese angiographically smooth coronary 
vessels that constrict in response to acetylcholine have early 
atherosclerosis not detectable by routine coronary angiogra- 
phy. 
There are many well known limitations of coronary angiog- 
raphy in diagnosing coronary artery disease, especially when 
there is mild or diffuse disease (10,17). Intravascular ultra- 
sound is a new technology that allows high resolution images of 
the vascular structure and overcomes these limitations of 
coronary angiography (18,19). The purpose of the present 
study was to use intravascular ultrasound to determine the 
presence and extent of atherosclerosis in patients with mild 
irregularities or smooth epicardial coronary arteries, as as- 
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sessed by coronary angiography, relating the ultrasound find- 
ings to the response of these vessels to infusion of acetylcho- 
line. 
Methods 
Patient selection. Patients referred to the Cardiac Cathe- 
terization Laboratory for evaluation of chest pain syndromes 
or for determination f coronary anatomy in association with 
other cardiac diseases were considered for this study. Patients 
with known, documented coronary artery disease were ex- 
cluded from the study (recent or remote myocardial infarction, 
unstable angina, previous coronary artery bypass grafting). 
Patients with clinically documented coronary artery spasm 
(transient ST segment elevation at rest during chest pain) were 
also excluded. Patients with severe chronic obstructive lung 
disease, renal failure (creatinine concentration >2 mg/dl 
[180/xmol/liter]) or known cerebrovascular disease were ex- 
cluded from the study. Any patients taking long-acting nitrates 
or calcium channel blocking agents had these medications 
withheld for 24 to 48 h before the study. The study was 
approved by the Mayo Clinic Institutional Review Board, and 
written informed consent was obtained from all patients. 
Diagnostic coronary angiography was performed in all 
patients before the study by using 6F catheters with a standard 
femoral percutaneous approach. Twenty-five hundred units of 
heparin was given intravenously after the arterial puncture. No 
nitroglycerin was given during the diagnostic procedure. Non- 
ionic contrast material was used for all patients. Patients were 
included in this study if they had the following: 1) angiographi- 
cally smooth coronary arteries, or 2) mild irregularities with no 
coronary artery lesion >30% lumen diameter stenosis by visual 
assessment in any major epicardial vessel. Patients were ex- 
cluded from the study if the proximal coronary arteries were 
<2.0 mm in diameter. Left ventriculography or echocardiog- 
raphy was performed in all patients for measurement of left 
ventricular function. 
Study design. After the diagnostic angiogram, an 8F guide 
catheter was positioned inthe ostium of the left main coronary 
artery', and an infusion catheter (length 135 cm, outer diameter 
3F, inner lumen >0.038 in. [0.10 cm]) was placed through the 
guide catheter selectively into the proximal eft anterior de- 
scending or circumflex coronary artery. An additional 5,000 U 
of heparin was given intravenously. Blood pressure, electrocar- 
diography (standard MCL 1 lead) and heart rate were moni- 
tored throughout the procedure. A single monoplane anglo- 
graphic view that best displayed the left anterior descending or 
circumflex coronary artery without foreshortening was selected 
from the diagnostic angiograms, and the image intensifier was 
fixed at this angle and height hroughout the procedure. 
A baseline angiogram was obtained after the catheters had 
been properly positioned. Nonionic contrast material (8 to 
12 ml) was injected by hand into the guide catheter to achieve 
optimal opacity of the coronary' arteries, and the images were 
recorded on 35-mm film. After this, a control infusion of 
isotonic saline solution was performed through the small 
infusion catheter positioned in the left anterior descending 
coronary artery by using a Harvard infusion pump at a rate of 
0.8 ml/min for a total duration of 3 min. At the end of 3 min, 
blood pressure, heart rate and electrocardiographic re ordings 
were measured, and another angiogram was obtained. The 
infusion was continued until after the angiogram was com- 
pleted. Three different infusions of acetylcholine were per- 
formed in a similar manner. The concentrations of acetyleho- 
line were 10 -6, 10 -5 and 10 -4 mol/liter. If a blood flow of 
80 ml/min in the coronary arteries i  assumed (20), then these 
infusions would achieve stimated coronary blood concentra- 
tions of acetylcholine of 10 -s, 10 -7 and 10 -6 rnol/liter (11). If 
there was severe constriction of the coronary arteries with any 
dose of acetylcholine, then the infusions were stopped. After 
each dose, angiography was repeated. After infusions of ace- 
tylcholine, 300/~g of nitroglycerin were given by an intracoro- 
nary route, and angiography was repeated within 2 min after 
the nitroglycerin was given. 
After the selective coronary infusions, intravascular ultra- 
sound imaging was performed. One of three intracoronary 
ultrasound systems (Cardiovascular Imaging Systems, Inter- 
therapy and Hewlett-Packard) was used in this study. Details 
of these systems have been described elsewhere (18,19). The 
intracoronary ultrasound catheters were inserted through the 
8F guide catheter and placed into the proximal and middle 
portions of the selected artery over a 0.014-in. (0.036 cm), high 
torque, floppy guide wire. After optimization ofthe ultrasound 
image, continuous real-time images were recorded on 0.5-in. 
videotape. Four to five segments of the coronary artery distal 
to the infusion catheter 0.5 to 1.0 cm apart were selected 
independently of the response to acetylcholine. These seg- 
ments were identified on the videotape recording of the 
ultrasound imaging, and the exact position of the ultrasound 
catheter in relation to the artery was recorded on cine film at 
each position. The location of the catheter as seen on the cine 
film at each segment position was used to correlate the 
identified ultrasound image with the angiographic segment. 
Study analysis. Analysis of artery diameter f om the cine 
films was done with a modification of the technique previously 
described from this institution (21,22). A diastolic still frame at 
each infusion (baseline, saline solution, acetylcholine times 
three and nitroglycerin) was selected from the cine film and an 
8 x 10-in. spot film was made. The different segments of the 
artery selected at the time of intracoronary ultrasound imaging 
were identified on the radiograph. By using a computer- 
interactive digitizing system, the outline of the contrast mate- 
rial within the lumen was digitized at each specific region of 
interest identified (21,22). The absolute diameter of the vessel 
lumen perpendicular to the long axis of the artery at the 
selected specific points of the artery was measured by using the 
guide catheter as the calibration standard. These measure- 
ments were made by an experienced observer with no knowl- 
edge of the ultrasound findings. 
There was a progressive directional change in the vessel 
diameters during acetylcholine infusions of increasing concen- 
trations. The response of each segment to the highest infusion 
JACC Vol. 26, No. I NISHIMURA ET AL. 43 
July 1995:41-9 CORONARY ATHEROSCLEROSIS 
dosage of acetylcholine was calculated in two ways: 1) The 
percent change in vessel diameter during acetylcholine infu- 
sion compared with vessel diameter at baseline (%Aacetylcho- 
line) was calculated; 2) to control for variations in underlying 
vasomotor activity, the response to acetylcholine was normal- 
ized to the maximally vasodilated diameter after nitroglycerin 
administration. Thus, the ratio of the vessel diameter during 
acetylcholine infusion to the diameter after administration f
intracoronary nitroglycerin (acetylcholine/nitroglycerin) was 
calculated. For each patient, the average response of all 
measured segments was calculated for both the %Aacetylcho- 
line and the acetylcholine/nitroglycerin ratio measurements. 
The average response of all measured segments was used in 
this study to account for the segmental heterogeneity seen in 
response to acetylcholine infusion (23). However, the average 
response of all measured segments for each patient had the 
same directional response as segments howing the greatest 
mean diameter change at peak acetylcholine infusion, as has 
been shown previously (11). 
Intraobserver variability in coronary artery diameter mea- 
surement was assessed by independent, blinded measurement 
of random segments in 20 patients. The percent intraobserver 
variability was 6 +_ 5% (mean -2_ SD). In 10 patients, two 
angiograms in the baseline state were obtained within 5 rain of 
each other. The percent variability in the measurements of 
random segments from the two separate angiograms was 4 _+ 
5%. 
For each coronary segment, a visual subjective analysis was 
performed from the cineangiogram to categorize the segments 
into 1) angiographically normal segments, and 2) segments 
with mild irregularities. This was arrived at by the consensus of 
two experienced angiographers who had no knowledge of the 
other results of the study. For each patient, angiographically 
normal segments were defined as no irregularities in any 
segment. 
An off-line computer-interactive analysis ystem was used 
to digitize the intracoronary ultrasound video images onto a 
256 × 256-bit matrix (24). Standard calibration markers di- 
rectly from the ultrasound image were used for calibration of 
absolute measurements. Histopathologic correlations have 
been established for interpretation f intravascular ultrasound 
images (19,24-26). In the presence of atherosclerotic plaque 
or diffuse intimal thickening, there is a three-layered appear- 
ance. A thick homogeneous inner layer represents he athero- 
sclerotic plaque; a darker middle layer represents he thinned 
media; and a bright surrounding area represents he adventitia 
(19,24,25). The following measurements were made at each 
specific segment of the artery that had been previously identi- 
fied: measured lumen area and potential lumen area (mea- 
sured at the leading edge of the dark medial band [18]). 
Percent area stenosis was defined as the plaque area divided by 
the potential lumen area. 
Coronary artery segments were considered free of measur- 
able atherosclerotic plaque if the ultrasound appearance ofthe 
vessel wall was homogeneous without layering or consisted of 
a thin homogeneous layer -<0.1 mm in diameter (26) (group 1 ), 
Figure 1. Intravascular ultrasound images demonstrate a visually 
normal coronary artery (top), an artery, with an eccentric plaque 
(middle) and an artery with a concentric plaque (bottom). Arrows 
indicate the lumen borders; hatched areas outline the measured 
plaque area. Calibration markers of 0.5 mm are shown. 
Eccentric plaque was defined as measurable plaque covering 
< 100% of the circumference of the vessel (group 2). Concen- 
tric plaque was defined as measurable plaque covering the 
entire circumference of the vessel (group 3) (Fig. 1). 
For each patient, normal intravascular ultrasound segments 
were defined as all segments visualized being free of measur- 
able atherosclerotic plaque. 
Statistics. The two-sample t test was used to test for 
differences in normally distributed ata, and the Wilcoxon 
rank-sum test was used in the nonnormally distributed cases. 
The relation between continuous factors was assessed with 
the Pearson or the Spearman correlation coefficient. The 
Spearman coefficient was used for nonnormally distributed 
data, and the Pearson coefficient was used for normally 
distributed ata. 
For this sample size, adequate power was available to detect 
a 30% point difference in percent change in %Aacetylcholine, 
if such a difference truly e~sted (beta 0.1, alpha 0.05). Ade- 
quate power was available to detect a 30% point difference in 
percent change in ace@choline/nitroglycerin, if such a differ- 
ence truly existed (beta 0.01, alpha 0.05). 
Results 
Patients. There were 32 patients who were initially entered 
into the study. Of these, three patients were excluded, one 
because the infusion catheter moved into a diagonal artery, 
one because of inadequate ultrasound images and one because 
of angiographic mages inadequate for measurement. There- 
fore, data from 29 patients were available for analysis (left 
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anterior descending coronary artery in 28, left circumflex 
coronary artery in 1; 15 men, 14 women; mean [_+SD] age 55 _+ 
11 years, range 31 to 75). Twenty-seven patients were referred 
to the Cardiac Catheterization Laboratory for chest pain, and 
two had cardiac atheterization forsymptoms of dyspnea. The 
mean ejection fraction was 66 -+ 15%, and the end-diastolic 
volume index was 85 _ 22 ml/m z. 
The mean cholesterol level was 215 _+ 51 mg/dl. Seventeen 
of the 29 patients had a cholesterol level >200 mg/dl. Eleven 
patients had a history of tobacco use (four active and seven in 
the past); eight had a positive family history of coronary 
disease (first-degree relative <50 years old with documented 
coronary artery disease); two had hypertension therapy; and 
one had insulin-dependent diabetes. Medications at the time 
of the study included beta-adrenergic re eptor blocking agents 
in four patients, salicylates in three and gemfibrozil n one. 
Three patients were receiving calcium-channel b ocking 
agents, but these were stopped at least 24 to 48 h before the 
procedure. None were receiving long-acting nitrates. 
Intravascular ultrasound findings. There were no compli- 
cations from insertion of the intravascular ultrasound catheter. 
The average time of the intravascular ultrasound examination 
was 3 rain. 
There were 144 coronary artery intravascular ultrasound 
segments analyzed. Of these, 76 had no visible plaque, and 68 
had definite atherosclerotic disease by intravascular ultra- 
sound. Forty-two segments had eccentric plaque, and the 
remaining 26 had concentric plaque. 
Seven of the 29 patients had no visible atherosclerotic 
plaque as assessed by intravascular ultrasound (group 1). The 
remaining 22 patients had visible atherosclerotic plaque in at 
least one segment on ultrasound images (group 2). 
Angiographie measurements. Fourteen of the 29 patients 
had angiographically normal arteries. The remaining 15 pa- 
tients had mild irregularities on angiography in at least one 
segment. 
There were no complications as a result of acetylcholine 
infusions. There was no significant change in blood pressure or 
heart rate response during the various infusions. Chest pain 
developed in two patients during the final infusion of 
10 -4 mol/liter of acetylcholine, which was reversed by intra- 
coronary nitroglycerin i fusion. 
There was no significant difference in coronary, artery 
diameter measurement at baseline and during saline infusion 
(2.31 _+ 0.5 mm vs. 2.27 ± 0.5 ram, p NS). The overall percent 
change during acetylcholine infusion in all patients was -9 _+ 
24%. With nitroglycerin i fusion, there was an overall vasodi- 
lation compared with that at baseline, with a mean increase in 
coronary artery segment diameter of 13 _ 15%. 
Relation of response to acetylcholine and intravascular 
ultrasound findings. The response of the coronary arteries to 
acetylcholine infusion was not related to the presence or 
absence of atherosclerosis a  assessed by intravascular ultra- 
sound (Fig. 2). Percent change in baseline segment diameter to 
that during acetylcholine infusion was - 14 ± 28% in the seven 
patients with no visible atherosclerosis on intravascular ultra- 
sound (group 1). This was not different from the -9 _+ 20% 
decrease in the 22 patients with visible atherosclerosis on 
intravascular ultrasound (group 2) (Fig. 3, top). The estimate 
of the difference in percent change was only 5% (95% confi- 
dence interval [CI] -14% to 25%). The ratio of the vessel 
diameter during acetylcholine infusion to that diameter after 
nitroglycerin was 0.78 + 0.26 in the seven patients with no 
visible atherosclerosis on intravascular ultrasound (group 1) 
and 0.82 + 0.19 in the 22 patients with visible atherosclerosis 
on intravascular ultrasound (group 2) (p = NS) (Fig. 3, 
bottom). The estimate of the difference in acetylcholine/ 
nitroglycerin ratio was 0.04 (95% CI -0.14 to 0.23). 
Table 1 shows the relation between the intravascular ultra- 
sound and angiographic findings in the 29 patients. Eight of the 
14 patients with angiographically normal coronary arteries had 
atherosclerotic disease on intravascular ultrasound imaging. 
Fourteen of 15 patients with mild irregularities noted on 
angiography had documented atherosclerotic disease on intra- 
vascular ultrasound imaging. There was no significant differ- 
ence in the changes with acetylcholine when patients were 
compared with regard to the following findings: 1) normal 
angiographic segments/normal intravascular ultrasound seg- 
ments versus 2) normal angiographic segments/abnormal in- 
travascular ultrasound segments versus 3) abnormal angio- 
graphic segments/abnormal intravascular ultrasound segments. 
There was no significant difference in either percent change 
with acetylcholine or the ratio of acetylcholine/nitroglycerin 
within these three groups. 
There were seven patients with no clinical risk factors and 
22 with at least one or more clinical risk factors, including 
serum cholesterol level >200 mg/dl, positive family history of 
coronary artery disease, history of hypertension with current 
medical therapy, diabetes mellitus or history of or current 
tobacco use. There was a greater percent change in vessel 
diameter during acetylcholine infusion than at the baseline 
state in patients with than without risk factors (-14 + 23% vs. 
4 _+ 8%, p = 0.003) (Fig. 4). 
Discuss ion  
The present study examined the in vivo vasomotor response 
in human coronary arteries of known atherosclerotic morphol- 
ogy documented by intravascular ultrasound. The results of 
this study in patients with chest pain syndromes are similar to 
those of a previous tudy in patients after cardiac transplanta- 
tion (27,28): The vasoactive response to acetylcholine in these 
patients is not related to the absence, presence or degree of 
underlying atherosclerosis. Vasoconstriction may occur in nor- 
mal segments and vasoditation in diffusely atherosclerotic 
segments. 
The present study is not in disagreement with previous 
angiographic studies because a more sensitive and specific 
method to determine the presence or absence of atheroscle- 
rotic lesions was used with intravascular ultrasound. Our 
patients were limited to those with angiographically normal or 
near-normal coronary arteries. Thus, patients with definite 
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Figure 2. Coronary angiograms (left) obtained at baseline 
and after infusion of 10 4 tool/liter of ace~lcholine and 
intravascular ultrasound images (right) of three representa- 
tive segments (a, b, c) in three patients after intracoronary 
administration f nitroglycerin. Top, There is diffuse angio- 
graphic vasoconstriction f the entire left anterior descending 
coronary artery after infusion of acetylcholine, with no 
measurable atherosclerotic plaque on the intravascular ultra- 
sound images. Middle, There is vasoconstriction in the mid- 
and distal left anterior descending coronary artery on coro- 
nary angiography after infusion of acetylcholine, with no 
measurable atherosclerotic plaque on the intravascular ultra- 
sound images. Bottom, There is vasodilation of the entire left 
anterior descending coronary artery on coronary angiography 
after infusion of acetylcholine. The intravascular ultrasound 
images demonstrate a thick-layered appearance of the vessel 
wall, indicating diffuse atherosclerosis. Symbols as in Figure 1. 
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Figure 3. Top, Percent change in coronary artery diameter during 
acetylcholine infusion versus the baseline state (% change ACH). 
There is no significant difference in overall percent change during 
acetylcholine infusion in patients with no evidence of atherosclerotic 
plaque on intravascular ultrasound (normal) versus those with visible 
atherosclerotic plaque in any segment on intravascular ultrasound 
(abnormal). Bottom, Plot of the ratio of the coronary artery diameter 
during acetylcholine infusion to the coronary artery diameter during 
maximal vasodilation with intravenous nitroglycerin (ACH/NTG). 
There was no significant difference in this ratio in the patients with no 
visible atherosclerotic disease on intravascular ultrasound versus those 
with disease on intravascular ultrasound. 
advanced atherosclerosis by angiography, who would be ex- 
pected to have a vasoconstrictive r sponse (6), were not 
included in the study. Previous studies (6-8) have shown a 
vasoconstrictive response in patients with mild irregularities of 
the left anterior descending coronary artery but with advanced 
stenosis in at least one other vessel; such patients with more 
advanced atherosclerosis were not included in our study. As 
previously shown (7-9,11-15), there was a relation between the 
Table 1. Relation of Intravascular Ultrasound and Angiographic 
Findings in Individual Patients 
Angiographic Findings 
IVUS Normal Irregularities 
Normal n - 6 n = 1 
%AACH i7 + 29 3 
ACH/NTG 0.74 _+ 0.26 1.03 
Plaque present n - 8 n 14 
%AACH -4  _+ 9 -12 _+ 24 
ACH/NTG 0.87 _+ 0.09 0.80 _+ 0.22 
Data presented are mean value _+ SD or number of patients. ACH/NTG 
ratio of vessel diameter during acetylcholine infusion to that after intracoronary 
nitroglycerin; IVUS = intravascular ultrasound; %AACH = percent change in 
diameter of coronary vessel during acetyleholine infusion versus diameter at 
baseline. 
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Figure 4. Percent change in coronary artery diameter during acetyl- 
choline infusion versus baseline (% change ACH) in patients without 
versus with risk factors. There was a significantly arger degree of 
vasoconstriction in patients with than without risk factors (p = 0.003). 
vasoconstrictive r sponse to acetylcholine and the risk factors 
for coronary artery disease. All segments dilated in response to 
nitroglycerin, indicating that the changes in response to ace- 
tylcholine were the result of a disturbance in endothelial 
function and were not related to underlying changes in vaso- 
motor tone. 
Previous clinical studies. A vasoconstrictor response usu- 
ally occurs in patients with definite angiographic oronary 
artery disease (6,8,9,29). A variable response to infusion of 
acetylcholine occurs in patients with angiographically normal 
coronary arteries or in those with mild irregularities (6-9,11- 
15,29,30). The variable response in earlier studies (6,30) was 
initially explained on the basis of different dosages of acetyl- 
choline, different methods of infusion (bolus administration vs. 
continuous infusion) and changes in heart rate and blood 
pressure during infusion. However, subsequent s udies found 
that vasodilation occurred when acetylcholine was infused into 
angiographically normal arteries in young patients with no risk 
factors and that vasoconstriction ccurred in angiographically 
normal arteries in older (9), hypertensive (12,14), or hyperlip- 
idemic patients (8,13,15) or in those with angiographic evi- 
dence of disease in other arteries (7). The vasoconstrictive 
response was directly related to the number of risk factors 
present (11). 
Recent studies (31) showed that vasodilation i  response to 
acetylcboline is attributed to release of endothelium-derived 
relaxing factor by muscarinic receptors (32) and is not due to 
prostaglandins or alpha-adrenoceptor mechanisms because it 
is inhibited by methylene blue, which blocks the cyclic 
guanosine monophosphate pathway. Thus, vasoconstriction in 
response to acetylcholine in human coronary arteries is due to 
endothelial dysfunction and was proposed (6,7,16,33) to occur 
in patients with angiographically normal coronary arteries 
because of early atherosclerosis that was not detected by 
conventional coronary angiography. 
Others (27,28) have suggested that a vasoconstrictor re- 
sponse to acetytcholine may occur in patients without athero- 
sclerotic disease, indicating that an abnormality of endothelial 
function may be present without morphologic atherosclerosis. 
The highly sensitive and specific information on the presence 
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Figure 5. Percent change in corona~ arter3, ." diameter during acetyl- 
choline infusion versus baseline (% change ACH) in the 144 individual 
segments. 
or absence of atherosclerotic plaque provided by intravascular 
ultrasound in the present study supports that hypothesis. In 
the animal model, abnormal responses to acetylcholine in the 
presence of hyperlipidemia were shown (34-36) to occur in the 
absence of atherosclerosis with the endothelium generally 
morphologically intact. Thus, early endothelial dysfunction 
without atherosclerosis in coronary arteries may represent an 
important early event predisposing to vasospasm. Mechanisms 
that have been proposed include attenuation of receptor- 
mediated stimulation, decreased synthesis of endothelium- 
derived relaxing factor (34), intimal trapping of endothelium- 
derived relaxing factor (37), a direct effect of low density 
lipoprotein (36) or decreased responsiveness of smooth muscle 
to endothelium-derived r laxing factor. Others (38) have sug- 
gested that a decreased endothelium-dependent r laxation 
may be due to the simultaneous release of a contracting 
substance. In patients with variant angina, substance P will 
cause coronary dilation in segments that constrict in response 
to acetylcholine, indicating that the mechanism of the produc- 
tion of endothelium-derived r laxing factor and the response 
of smooth muscle remains preserved (39). 
The presence of diffuse atherosclerosis identified by intra- 
vascular ultrasound in the present study did not necessarily 
predict a vasoconstrictive r sponse to acetylcholine. A recent 
study (23) has also shown that vasodilation may occur in 
patients with known coronary artery disease, indicating that 
endothelial function is not irreversible and diffusely lost in the 
presence of atherosclerotic disease. Patchy segmental re- 
sponses in the same artery have been documented, suggesting 
that local factors may be important in determining endothelial 
function (23). There was less vasoconstriction i  response to 
acetylcholine in segments consisting of concentric plaques 
(Fig. 5). This suggests that concentric atherosclerotic involve- 
ment may produce acicatrization effect hat prevents vasocon- 
striction. 
Role of endothelium-derived relaxing factor in humans. 
The role of endothelium-derived r laxing factor in clinical 
coronary disease syndromes remains uncertain, but there have 
been recent studies implicating its importance. Impaired 
endothelium-dependent cholinergic oronary vasodilation in 
patients with visually normal arteries on coronary angiography 
may contribute to the pathogenesis of myocardial ischemia nd 
angina in patients with syndrome X (40,41). There is an 
increased sensitivity of coronary arteries that respond with a 
vasoconstrictive r sponse mediated by acetylcholine to con- 
striction with mental stress (29) or catecholamines (16), sug- 
gesting that altered vasomotor tone may play a role in the 
production of coronary ischemia in stable disease. Infusion of 
acetylcholine immediately after myocardial infarction pro- 
duced a much greater degree of vasoconstriction in the infarct- 
related than the noninfarct-related artery, suggesting that this 
response may be related to the pathogenesis of myocardial 
infarction (42). An impaired response in arteries that are 
prone to develop atherosclerosis, such as in branch points (43) 
and transplanted hearts (33), emphasizes the potential role of 
endothelial dysfunction in the development of future athero- 
sclerosis. Thus, the response of coronary arteries to acetylcho- 
line as a measure of endothelial function may be an important 
tool for future investigations into clinical coronary artery 
syndromes. 
Limitations of the study. Multiple studies (19,24,25) doc- 
umented the ability of intravascular ultrasound to detect and 
quantitate the amount of atherosclerosis when images are 
correlated with histopathologic specimens. Thus, the presence 
of a thick-layered appearance ofthe vessel wall on intravascu- 
lar ultrasound is a reliable marker for atherosclerosis. How- 
ever, mild degrees of intimal thickening may not be observed 
on intravascular ultrasound imaging until the intimal ayer is 
sufficiently thick, so that the overall thickness of the vessel 
becomes resolvable at 30 MHz. Intimal thickening will nor- 
mally occur with age and may even exceed the dimension of the 
underlying medial layer by age 30 years (44). The threshold on 
the instrument used in the study for detection of intimal 
thickening is -178 ~m (26), and intravascular ultrasound may 
not be sensitive to intimal thickening below this threshold. 
The number of patients in the present study was relatively 
small, and the confidence intervals of the difference in re- 
sponse to acetylcholine between groups 1 and 2 were relatively 
large. However, the demonstration that several group 1 pa- 
tients had vasoconstriction and several from group 2 had 
vasodilation was supportive of the hypothesis that endothelial 
function is not solely dependent on coronary artery morphol- 
ogy (Fig. 2). The quantitative analysis of the diameter of 
the coronary artery segments did not use the biplane 
videodensitometrically-automated an lysis averaging multiple 
end-diastolic frames, as has been described in previous tudies. 
Nonetheless, the intraobserver variability of <6% and the low 
variability between measurements on two separate angiograms 
at baseline demonstrate he reliability and reproducibility of 
this technique. There was no measurement of blood flow and, 
thus, the present study did not control for the potential 
confounding effects of patient-to-patient variability on flow- 
dependent vasodilation, which averages 7% (28). The concen- 
tration of acetylcholine used in our study was similar to that 
used in several previous studies (6,8,11,28); however, these 
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concentrations a sume a blood flow of 80 ml/min to achieve 
final concentrations of 10 a to 10 ~' tool/liter. Thus, in the 
presence of higher corona U flow rates, the final intracoronary 
concentration would be less. 
A bias may be present in the patient cohort because the 
majority of patients selected for our study had coronau 
angiography for evaluation of chest pain syndromes. It is 
possible that these patients, thcrefore, may have some intrinsic 
abnormality and corona~' reactivity to vasoactive stimuli and 
may not be representative of all patients with angiographically 
normal coronary arteries. Nonetheless, even in this patient 
subgroup, these findings indicate that the relation between 
morphologic atherosclerotic disease and endothelial dysfunc- 
tion is more complex than previously suggested. 
We thank David T. Smyrk, BA for work on thc angiographic and ultrasound 
images, Denise A. Skoda for secretarial assistance and Kristine Menkc. BA tier 
technical support. 
References 
1. Maseri A. The changing face of angina pcctoris: practical implications. 
Lancet 1983;1:746-9. 
2. Maseri A. Role of coronary artery spasm in symptomatic and silent ischemia. 
J Am Coil Cardiol 1987;9:249-62. 
3. Furchgott RF. Role of cndothelium in responses of vascular smooth muscle. 
Circ Res 1983;53:557-73. 
4. Bassenge E, Busse R. Endothelial modulation of cnronary tone. Prog 
Cardiovasc Dis 1988;30:349-80. 
5. Vanhoutte PM. The cndothelium--modulalor of vascular smooth-muscle 
tone. N Engl J Med 1988;319:512-3. 
6. Ludmer PL, Selw)'u AP, Shook TL. ct al. Paradoxical vasoconstriction 
induced by ace~lcholine in atherosclerotic coronary arteries. N Engl J Med 
1986;315:1046-51. 
7. Werns SW, Walton JA, Hsia Htt, Nabel EG, Sanz ML, Pitt B. Evidence of 
endothelial dysfunction in angiographically normal coronary arteries of 
patients with corona U artery disease. Circulation 1989;79:287 91. 
8. Zeiher AM, Drexler H, Wollschl~iger H. Just H. Modulation of corona U
vasomotor tone in humans: progressive endothelial dysfunction with differ- 
ent early stages of coronary atherosclerosis. Circulation 1991;83:391-401. 
9. Yasue H, Matsuyama K, Matsuyama K, Okumura K, Morikami Y, Ogawa H. 
Responses of angiographically normal human coronary arteries to intracuro- 
nary injection of acetylcholine by age and segment: possible role of early 
coronary atherosclerosis. Circulation 19911;81:482-90. 
10. Arnett EN, lsner JM, Redwood DR, el al. Coronary artery narrowing in 
coronary heart disease: comparison of cineangiographic and necropsy find- 
ings. Ann Intern Med 1979;9h351!-6. 
11. Vita JA, Treasure CB, Nabel EG. el al. Coronary vasomotor response to 
accb'lcholinc relates to risk factors fnr coronary artery disease. Circulation 
1990;81:491-7. 
12. Treasure CB, Manoukian SV, Klcin Jh, et al. Epicardial coronary arteu 
responses to acetylcholine are impaired in hypertensive patients. Circ Rcs 
1992;71:776- 81. 
13. Drexler H, Zeiher AM. Endothelial function m human coronary arteries in 
vivo: focus on hypercholesterolemia. Hypertension 1991;18 Suppl I1:11-90-9. 
14. Brush JE Jr, Faxon DP, Salmon S. Jacobs AK, Ryan TJ. Abnormal 
endothelium-dependent coronary vasomotion i hypertensive patients. J Am 
Coil Cardiol 1991;19:809-15. 
15. Kuhn FE, Mohler ER, Satler LF. Reagan K, Lu DY, Racklcy CE. Effects of 
high-density lipoprotein on acetylcholine-induced coronary vasoreactivity. 
Am J Cardiol 1991;68:1425-30. 
16. Vita JA, Treasure CB, Yeung AC, et al. Patients with evidence of coronary,' 
endothelial dysfunction as assessed by acetylcholine infusion demonstrate 
marked increase in sensitivity to constriclor effects of catecholamincs. 
Circulation 1992;85:1390-7. 
17. McPherson DD, Hiratzka LF, Lamberth WC, et aL Delineation of the extent 
of coronary atherosclerosis byhigh-frequency epicardial echocardiography. 
Ix" Engl J Med 1987;316:304-9. 
18. Pinto FJ, St. Goar FG, Fischell TA, et al. Nitroglycerin-induced corona~, 
vasodilation i  cardiac transplant recipients: evaluation with in vivo intra- 
coronary ultrasound. Circulation 1992:85:69-77. 
19. Yobis JM, Mallery J, Mahon D, et al. Intravascular ultrasound imaging of 
human coronary arteries in vivo: analysis of tissue characterizations with 
comparison to in vitro histological specimens. Circulation 1991;83:913-26. 
20. Ganz W, Tamura K, Marcus HS, Donoso R, Yoshida S, Swan HJC. 
Measurcmcnt of coronary sinus blood flow by continuous thermodilution i
man. Circulation 1971;44:181-95. 
21. Lam JYT, Chesebro JH, Steele PM, Badimon L, Fuster V. ls vasospasm 
related to platelet deposition? Relationship in a porcine preparation of 
artcrial injury in vivo. Circulation 1987;75:243-8. 
22. Steele PM, Chesebro JH, Stanson AW, et ah Balloon angioplasty: natural 
history of thc pathophysiologic responsc to injury in a pig model. Circ Res 
1985;57:105-12. 
23. EI-Tamimi H, Mansour M, Wargovich TJ, et al. Constrictor and dilator 
responses to intracoronary acetylcholine in adjacent segments of the same 
coronary artery in patients with coronary artery disease: endothelial function 
revisited. Circulation 1994;89:45-51. 
24. Nishimura RA, Edwards WD, Warnes CA, et al. Intravascular ultrasonic 
imaging: in vitro validation and pathologic orrelation. J Am Coil Cardiol 
1990:16:145-54. 
25. Gusscnhoven EJ, Essed CE, Lancde CT, et al. Arterial wall characteristics 
determined byintravascular ultrasound imaging: an in vitro study. J Am Coll 
Cardiol 1989;14:947-52. 
26. Fitzgerald PJ, St. Goar FG, Connolly AJ, et al. lntravascular ultrasound 
imaging of the coronary, artcries: is three layers the norm? Circulation 
1992;86:154-8. 
27. Anderson T J, Meredith IT, Uehata A, et ah Functional significance of 
intimal thickening as detected by intravascular ultrasound early and late after 
cardiac transplantation. Circulation 1993:88:1093 100. 
28. Drexler H, Fischell TA, Pinto FJ, et al. Effect of L-arginine on coronary 
endothelial function in cardiac transplant recipients: relation to vessel wall 
morphology. Circulation 1994;89:1615-23. 
29. Yeung AC, Vckshtein VI, Krantz DS, ct al. The effect of atherosclerosis on
the vasomotor response of coronary arteries to mental stress. N Engl J Med 
199I;325:1551-6. 
30. Horio Y, Yasue H, Rokutanda M, et al. Effects of intracoronary injection of 
acetylcholine on coronary arterial diameter. Am J Cardiol 1980;57:984-9. 
3 I. Linder L, Kiowski W, Biihler FR, Liischer TF. lndirect evidence for release 
of endothelium-derived r laxing factor in human forearm circulation in vivo: 
blunted response in essential hypertension. Circulation 1990;81:1762-7. 
32. Hodgson J McB, Marshall JJ. Direct vasoconstriction a d endothelium- 
dependent vasodilation: mechanisms of acctylcholine ffects on coronary 
flow and arterial diameter in patients with nonstenotic oronary arteries. 
Circulation 1989;79:1043-51. 
33. Fish RD, Nabel EG, Selwyn AP, et al. Responses of coronary arteries of 
cardiac transplant patients to acetylcholine. J Clin Invest 1988;81:21-3l. 
34. Verbeuron TJ, Jordaens FH, Zonnekeyn LL, Van Hove CE, Coene M-C, 
Herman AG. Effect of hypercholesterolemia on vascular reactivity in rabbit: 
h Endothelium-depcndent and endothelium-independent contractions and 
relaxations in isolated arteries of control and hypercholesterolemic rabbits. 
Circ Res 1986;58:552-64. 
35. Jayakody L, Senaratne M, Thomson A, Kappagoda T. Endothelium- 
dependent relaxation in experimental therosclerosis in the rabbit. Circ Res 
1987;60:251-64. 
36. Andrews HE, Bruckdorfer KR, Dunn RC, Jacobs M. Low-density lipopro- 
teins inhibit endothelium-dependent r laxation in rabbit aorta. Nature 
1987;327:237-9. 
37. Kanamuru K, Waga S, Tocfiio H, Nagatani K. The effect of atherosclerosis 
on cndothelium-dependent relaxation in the aorta and intracranial arteries 
of rabbits. J Neurosurg 1989;70:793-8, 
38. l.uscher TF, Vanhoune PM. Endothelium-dependent co ractions to ace- 
tylcholine in the aorta of the spontaneously h pertensive rat. Hypertension 
1986;8:344-8. 
39. Yamamoto H. Preserved endothelial function in the spastic segment of the 
human epicardial coronary artery in patients with variant angina--role of 
substance P in evaluating endothelial function. Eur Heart J 1993;14 Suppl 
1:118-22. 
JACC Vol. 26, No. 1 N1SHIMURA ET AL. 49 
July 1995:41-9 CORONARY ATHEROSCLEROSIS 
40. Vrints CJM, Bull H, Hitter E, Herman AG, Snocck JP. Impaired cndothelium- 
dependent cholinergic coronary vasodilation i patients with angina nd normal 
coronary" arteriograms. J Am Coil Cardiol 1992:19:21-31. 
41. Kessler KM. Syndrome X: the epicardial view [editorial comment]. J Am 
Coil Cardiol 1992;19:32 3,
42. Okumura K, Yasue H, Matsuyama K, et al. Effect of acetylcholine on the 
highly stenotic oronary, arteu: difference between the constrictor esponse 
of the infarct-related coronary artery and that of the noninfarct-related 
arte~'. J Am Coil Cardiol 1992;19:752 8. 
43. MeLenachan JM, Vita J, Fish RD, et al. Early evidence of endothelial 
vasodilator dysfunction at coronary branch points. Circulation 1990;82: 
1169-73. 
44. Velican C, Velican D. Study of coronary intimal thickening. Atherosclerosis 
1985 ;56:331 - 44. 
